CEO & President
Pluristem Therapeutics
(NASDAQ: PSTI)
Yaky Yanay is the CEO and President of the regenerative medicine company, Pluristem (Nasdaq, TASE: PSTI) bringing over 20 years of management experience in executive leadership roles in the high-tech and healthcare sector.
He is the former Co-Chairman and a current Board Member of the Israel Advanced Technology Industries (IATI). The IATI is the largest umbrella organization representing the life science and high-tech industries in Israel.
Prior to joining Pluristem, Yaky was the Chief Financial Officer of Elbit Vision Systems Ltd., a leading machine vision company and served as manager in the high-tech sector at Ernst & Young Israel.
Yaky holds a bachelor’s degree with honors in Business Administration and Accounting and is a Certified Public Accountant in Israel.